GlassScriptPhysician profile
Almois Mohamad
NPI 1346361169
$7,377.53
in general payments reported to CMS, 2019-2025
29 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,411 · 2020: $719 · 2021: $555 · 2022: $296 · 2023: $236 · 2024: $1,811 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440 · Travel and Lodging: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,439.76 |
| Travel and Lodging | $956.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,137.48 | 2019-2025 | Varithena Administration Pack, Emblem Mri S-Icd, Watchman Flx |
| Abiomed | $1,583.65 | 2019-2021 | |
| Penumbra, INC. | $1,370.68 | 2024 | Indigo System, Penumbra System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $639.48 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $291.84 | 2019-2023 | Farxiga |
| Philips North America LLC | $184.17 | 2019-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $175.02 | 2021-2023 | Verquvo |
| Amgen INC. | $162.01 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $122.93 | 2020-2025 | |
| Inari Medical, INC. | $85.76 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $79.08 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.53 | 2021-2022 | |
| Pfizer INC. | $61.06 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.41 | 2023-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $37.25 | 2025 | Assure Wcd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $36.60 | 2025 | Artix Mt |
| Bard Peripheral Vascular, INC. | $35.00 | 2024-2025 | Venovo |
| Cardiva Medical, INC. | $29.85 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Surmodics, INC. | $28.80 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Janssen Pharmaceuticals, INC | $27.64 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.38 | 2023 | Camzyos |
| Cook Medical LLC | $20.14 | 2024 | Zilver Ptx |
| Medtronic, INC. | $19.33 | 2025 | Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $18.97 | 2022 | |
| Braemar Manufacturing, LLC | $18.67 | 2019 | |
| Medtronic Vascular, INC. | $17.99 | 2019 | |
| Akcea Therapeutics, INC. | $16.33 | 2021 | |
| Angiodynamics, INC. | $16.32 | 2022 | |
| Terumo Medical Corporation | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Almois Mohamad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.